Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | BTN3A1 | O00481 | 4/20 | 0.43 |
| ▸ | MVD | P53602 | 3/20 | 0.33 |
| ▸ | FNTA | P49354 | 3/20 | 0.32 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16855741 | 1.00 | FDPS (0.47) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL412533 | 1.00 | FDPS (0.47) | FDPSBLMTDP1BTN3A1MVD | |
| Ammonia Solution, Strong SCHEMBL28227868 | 0.97 | FDPS (0.45) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL9580811 | 0.97 | FDPS (0.45) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL10862597 | 0.97 | FDPS (0.45) | FDPSBLMTDP1BTN3A1MVD | |
| Ammonia Solution, Strong SCHEMBL28227867 | 0.97 | FDPS (0.45) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL19387807 | 0.94 | FDPS (0.53) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL889928 | 0.94 | FDPS (0.53) | FDPSBLMTDP1BTN3A1MVD | |
| Ammonia Solution, Strong SCHEMBL28569612 | 0.92 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD | |
| SCHEMBL1577193 | 0.92 | FDPS (0.50) | FDPSBLMTDP1BTN3A1MVD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118369335-A | N1-modified pseudouridine and application thereof in mRNA synthesis | 上海吉量医药工程有限公司 | 2024-07-19 | — | — | CN | disclosed |
| WO-2023131254-A1 | PSEUDOURIDINE MODIFIED AT N1 POSITION AND USE THEREOF IN MRNA SYNTHESIS | 上海吉量医药工程有限公司 | 2023-07-13 | — | — | WO | disclosed |
| EP-1546399-B1 | TERMINAL PHOSPHATE BLOCKED NUCLEOSIDE POLYPHOSPHATES | GE HEALTHCARE BIO SCIENCES (US) | 2012-02-29 | — | — | EP | disclosed |
| US-7452698-B2 | Terminal phosphate blocked nucleoside polyphosphates | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20070292879-A1 | TERMINAL PHOSPHATE BLOCKED NUCLEOSIDE POLYPHOSPHATES | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2007-12-20 | — | — | US | disclosed |
| US-7256019-B2 | Terminal phosphate blocked nucleoside polyphosphates | GE HEALTHCARE BIO-SCIENCES CORP. (US) | 2007-08-14 | — | — | US | disclosed |
| EP-1546399-A4 | TERMINAL PHOSPHATE BLOCKED NUCLEOSIDE POLYPHOSPHATES | GE HEALTHCARE BIO SCIENCES (US) | 2007-07-25 | — | — | EP | disclosed |
| EP-1546399-A2 | TERMINAL PHOSPHATE BLOCKED NUCLEOSIDE POLYPHOSPHATES | Amersham Biosciences Corp. (US) | 2005-06-29 | — | — | EP | disclosed |
| US-20040048300-A1 | Terminal phosphate blocked nucleoside polyphosphates | GLOBAL LIFE SCIENCES SOLUTIONS USA LLC | 2004-03-11 | — | — | US | disclosed |
| WO-2004020602-A2 | TERMINAL PHOSPHATE BLOCKED NUCLEOSIDE POLYPHOSPHATES | AMERSHAM BIOSCIENCES CORP (US) | 2004-03-11 | — | — | WO | disclosed |